ergotamine has been researched along with metoclopramide in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (38.24) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 8 (23.53) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Leyton, M; Wilkinson, M; Williams, K | 1 |
| Liaño, H | 1 |
| Eldor, J; Schwartzberg, M | 1 |
| Pradalier, A; Vincent, D | 1 |
| Saadah, HA | 1 |
| Spierings, EL | 1 |
| Norekian, TP | 1 |
| Richter, R | 1 |
| Wilkinson, M | 2 |
| Gunderson, CH | 1 |
| Turner, P | 1 |
| Peatfield, R | 1 |
| Damasio, H | 1 |
| Blau, JN | 1 |
| Lang, WJ; Woodman, OL | 1 |
| Lewis, RH | 1 |
| Anaya Ordóñez, S; Matas Hoces, A | 1 |
| Graf, WD; Riback, PS | 1 |
| Geraud, G; Gómez, JP; Henry, P; Joffroy, A; Lainez, JM; Le Jeunne, C; Liaño, H; Pradalier, A; Titus i Albareda, F | 1 |
| Kozubski, W; Stepień, A | 1 |
| Barann, M; Brüss, M; Urban, BW; Walkembach, J | 1 |
| Allonen, H; Hakkarainen, H | 1 |
| Egberts, AC; Tijssen, CC; Wammes-van der Heijden, EA | 1 |
| Alshehri, MM; Alzoman, NZ; Elshahed, MS; Maher, HM; Olah, IV; Rizk, MS; Sultan, MA | 1 |
| Amble, NM; Amundsen, S; Nordeng, H; Poole, AC; Øvrebø, TG | 1 |
| Abdelhamid, NS; Anwar, BH; Farid, NF; Magdy, MA; Naguib, IA | 1 |
5 review(s) available for ergotamine and metoclopramide
| Article | Year |
|---|---|
[Current treatment of migraine].
Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents | 1992 |
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
Practical aspects of the pharmacotherapy of headache.
Topics: Analgesics; Antidepressive Agents, Tricyclic; Ergotamine; Headache; Humans; Metoclopramide; Propranolol; Serotonin Antagonists; Vasoconstrictor Agents | 1992 |
[Pharmacotherapy of migraine--indications and experiences].
Topics: Aspirin; Drug Therapy, Combination; Ergotamine; Humans; Metoclopramide; Migraine Disorders | 1988 |
Pharmacologic treatment of recurrent pediatric headache.
Topics: Acetaminophen; Adolescent; Adrenal Cortex Hormones; Analgesics; Aspirin; Child; Child, Preschool; Ergotamine; Humans; Methylamines; Metoclopramide; Migraine Disorders; Narcotics; Phenothiazines; Recurrence; Sumatriptan; Sympathomimetics; Vasoconstrictor Agents | 1995 |
5 trial(s) available for ergotamine and metoclopramide
| Article | Year |
|---|---|
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
[Sumatriptan in the treatment of acute migraine: its role in primary health care].
Topics: Acute Disease; Administration, Oral; Algorithms; Aspirin; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Humans; Injections, Subcutaneous; Metoclopramide; Migraine Disorders; Recurrence; Sumatriptan | 1994 |
Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Analgesics; Aspirin; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ergotamine; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Nausea; Patient Acceptance of Health Care; Safety; Sleep Stages; Treatment Outcome; Urea | 1999 |
[Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks].
Topics: Adult; Aged; Analgesics, Non-Narcotic; Aspirin; Caffeine; Central Nervous System Stimulants; Dopamine Antagonists; Drug Therapy, Combination; Ergotamine; Female; Humans; Lysine; Male; Metoclopramide; Middle Aged; Migraine Disorders; Poland; Time Factors; Treatment Outcome | 2004 |
Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks.
Topics: Acute Disease; Adult; Dopamine Antagonists; Drug Therapy, Combination; Ergotamine; Female; Humans; Metoclopramide; Middle Aged; Migraine Disorders; Treatment Outcome; Vasoconstrictor Agents | 1982 |
25 other study(ies) available for ergotamine and metoclopramide
| Article | Year |
|---|---|
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Observations on the treatment of an acute attack of migraine.
Topics: Acute Disease; Analgesics; Diazepam; Ergotamine; Female; Headache; Humans; Hypnotics and Sedatives; Length of Stay; Male; Metoclopramide; Migraine Disorders; Rest; Sleep | 1978 |
Ergotamine-metoclopramide for migraine: is it enough?
Topics: Drug Combinations; Ergotamine; Humans; Metoclopramide; Migraine Disorders | 1992 |
Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine.
Topics: Adult; Caffeine; Drug Combinations; Ergotamine; Humans; Metoclopramide; Middle Aged; Migraine Disorders; Naproxen; Retrospective Studies | 1992 |
[The neurons that determine the passive defense reaction in the pteropod mollusk Clione limacina].
Topics: Animals; Ergotamine; Escape Reaction; Ganglia; In Vitro Techniques; Metoclopramide; Microelectrodes; Mollusca; Neural Inhibition; Neurons; Physical Stimulation | 1989 |
Migraine--treatment of acute attack.
Topics: Acetaminophen; Acute Disease; Aspirin; Caffeine; Ergotamine; Ergotamines; Humans; Metoclopramide; Migraine Disorders; Sleep; Time Factors | 1985 |
Management of the migraine patient.
Topics: Amitriptyline; Analgesics; Diagnosis, Differential; Diet; Ergotamine; Humans; Hypnotics and Sedatives; Methysergide; Metoclopramide; Migraine Disorders; Oxygen; Propranolol; Stress, Physiological; Verapamil | 1986 |
Adverse reactions to drugs in migraine: some recent reports.
Topics: Domperidone; Ergotamine; Humans; Metoclopramide; Migraine Disorders | 1985 |
Treatment of the acute migraine attack--current status.
Topics: Acetaminophen; Aspirin; Drug Therapy, Combination; Ergotamine; Ergotamines; Humans; Metoclopramide; Migraine Disorders | 1983 |
Migraine. Current concepts of pathogenesis and treatment.
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cluster Headache; Ergotamine; Female; Humans; Lithium; Lithium Carbonate; Male; Methysergide; Metoclopramide; Migraine Disorders; Pizotyline; Premedication; Propranolol | 1983 |
Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
Topics: Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Metoclopramide; Migraine Disorders; Vascular Headaches | 1984 |
A plain man's guide to the management of migraine.
Topics: Acetaminophen; Aspirin; Ergotamine; Headache; Humans; Metoclopramide; Migraine Disorders; Sleep | 1982 |
Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Coronary Circulation; Dogs; Dopamine; Ergotamine; Female; Heart Rate; Male; Metoclopramide; Propranolol; Renal Circulation; Vasodilator Agents | 1982 |
How I manage migraine.
Topics: Aspirin; Ergotamine; Female; Humans; Metoclopramide; Migraine Disorders; Relaxation Therapy; Tranquilizing Agents | 1981 |
Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.
Topics: Adrenergic alpha-Agonists; Animals; Cell Line; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergotamine; Humans; Inhibitory Concentration 50; Kinetics; Membrane Potentials; Membrane Transport Proteins; Metoclopramide; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Transfection | 2005 |
Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile.
Topics: Adolescent; Adult; Aged; Aspirin; Cardiovascular Diseases; Drug Combinations; Ergotamine; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Tryptamines; Vasoconstrictor Agents | 2009 |
Capillary electrophoretic determination of antimigraine formulations containing caffeine, ergotamine, paracetamol and domperidone or metoclopramide.
Topics: Acetaminophen; Caffeine; Domperidone; Drug Combinations; Drug Stability; Electrophoresis, Capillary; Ergotamine; Hydrogen-Ion Concentration; Limit of Detection; Linear Models; Metoclopramide; Migraine Disorders; Osmolar Concentration; Reproducibility of Results; Tablets; Tartrates; Temperature | 2013 |
Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women.
Topics: Adolescent; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Breast Feeding; Cross-Sectional Studies; Drug Utilization; Ergotamine; Female; Humans; Metoclopramide; Middle Aged; Migraine Disorders; Norway; Patient Education as Topic; Postpartum Period; Pregnancy; Surveys and Questionnaires; Tryptamines; Young Adult | 2016 |
Validated ecofriendly chromatographic method for quantitative determination of anti-migraine quaternary mixture.
Topics: Acetaminophen; Caffeine; Chromatography, Thin Layer; Drug Compounding; Ergotamine; Metoclopramide; Molecular Structure | 2020 |